Researchers will conduct a clinical trial evaluating an adjunct treatment for koalas receiving antimicrobial therapy for chlamydia, a wide-spread and potentially fatal disease in this species.

Researchers will investigate the validity of using hemolymph analysis (similar to blood analysis in mammals) to assist in die-off investigations of freshwater mussels in Tennessee’s Cinch River.

Researchers will establish appropriate dosing for the commonly used pain medication meloxicam for Pacific harbor seals and California sea lions.

Researchers will identify immune system genes associated with meningoencephalitis of unknown origin, a common inflammatory central nervous system disease in dog

Researchers will evaluate two types of rabies vaccines to determine any effect on the resistance to unrelated infectious and parasitic diseases, and if this effect differs between males and females.

Researchers will study the genetics of drug response variability in dogs as a first step toward developing a novel, drug sensitivity test to increase drug safety and efficacy for individual patients.

Researchers will investigate brain function, brain metabolism and gut microbiome in dogs to distinguish between epileptic seizures and an episodic movement disorder called paroxysmal dyskinesia – commonly mistaken for epileptic seizures – to improve diagnosis and appropriate treatment.